Title: Chart: US marijuana industry’s economic impact could hit $80 billion by 2022
Author: MJ Biz
Date: 30 May 2018
URL: https://mjbizdaily.com/chart-us-marijuana-industrys-economic-impact-could-reach-80-billion-by 2022/utm_medium=email&utm_source=newsletter&utm_campaign=daily_052918&utm_content=&utm_term=&elqTrackId=1b94f6ee65d446138f114575109c215c&elq=95e257f1a5ce4da0bb30dc9e11a1d86b&elqaid=277&elqat=1&elqCampaignId=153
The U.S cannabis industry could pump nearly $80 billion on an annual basis into the nation’s economy by 2022, a staggering figure that highlights the true reach of the marijuana industry.
This data is particularly valuable to marijuana businesses looking to show the benefits of legalization to legislators and policymakers.
That’s because it can help them understand the importance of the cannabis industry to the larger U.S. economy – and how much more important it will become.
US Hemp Roundtable Report
Last Tuesday, the DEA issued an internal directive to its agents concerning the legality of hemp and hemp-derived products. The key language:
Products and materials that are made from the cannabis plant and which fall outside the CSA definition of marijuana (such as sterilized seeds, oil or cake made from the seeds, and mature stalks) are not controlled under the CSA. Such products may accordingly be sold and otherwise distributed throughout the United States without restriction under the CSA or its implementing regulations. The mere presence of cannabinoids is not itself dispositive as to whether a substance is within the scope of the CSA; the dispositive question is whether the substance falls within the CSA definition of marijuana.
Further, they clarified the controversial “marijuana extract” rule:
To be clear, the DEA believes that it has no enforcement authority over hemp or hemp products that are excluded from the Controlled Substances Act (CSA). This should include any product derived from hemp grown as part of a Farm Bill-authorized pilot program, since the Farm Bill explicitly “notwithstands” the CSA. (This interpretation was confirmed by the Ninth Circuit Court of Appeals which stated the Farm Bill “contemplates potential conflict between the Controlled Substances Act and preempts it.”) This exemption should also include any “non-psychoactive” imported hemp products as exempted from the CSA by the Ninth Circuit in its HIA v. DEA decision in 2004.
We write “should” because the DEA, yet again, frustratingly fails to specifically list these exceptions. But the absence of them taking any enforcement actions against Farm Bill hemp products signals that they understand that any interference with the interstate sale of such products would violate a clear legal mandate, passed several times by Congress, as recently as this March. And the Roundtable will aggressively address any attempt to violate this law.
As our General Counsel, Jonathan Miller, wrote this weekend for the website Kentucky Sports Radio, a promising young football player was cut by the Auburn Tigers for using hemp-derived CBD for his epileptic seizures. Auburn claims that this use is a violation of NCAA rules that prohibit the use of any product that contains any trace of THC.
The Roundtable finds this an outrageous action and is exploring ways to reverse this decision. It runs directly counter to the recent decision of the World Anti-Doping Agency to drop CBD from its list of prohibited substances. We ultimately hope that this turns into yet another example of a misguided enforcement decision resulting in a popular backlash in favor of hemp and hemp-derived CBD.
In a report issued by the Centers for Disease Control (CDC) last Thursday, synthetic products falsely labeled as CBD were blamed for 52 Utahans getting sick in late 2017. The CDC recommended that states set up regulatory and control systems “to minimize the risk for recurrences of this emerging public health threat.”
The Roundtable strongly supports law enforcement efforts to crack down on products that are falsely labeled as hemp or as CBD. The bad actor companies who make these products are a black eye on the industry. That’s why the Roundtable is working so hard to develop standards, best practices and self-regulation for the industry. (Learn more and have your say at this link).
Any effort to regulate hemp and hemp products, however, should not fall into the trap of over-regulation, in ways that will deny consumers the ability to purchase products, such as legitimate hemp-derived CBD, which the World Health Organization recently has declared as safe and non-addictive. We look forward to working with federal and state officials to honor our special duty to consumers to demonstrate our products are safe, and to law enforcement, to demonstrate our products are legal.
So many of the issues faced by the hemp industry can be addressed once and for all by passage of the Hemp Farming Act of 2018, which would permanently legalize hemp. Please click the button below to use our portal to contact your Members of Congress. It will only take you a few minutes – and it could make all of the difference.
Title: Study: Deadly pesticide use is up at illegal California pot farms
Date: 30 May 2018
An alarming increase in the use of a highly toxic and banned pesticide at illegal marijuana farms hidden on public land in California is leading U.S. and state officials to team up on an issue that recently divided them: pot.
They announced Tuesday that they will use $2.5 million in federal money to target illegal grows even as they remain at odds over the drug and other issues. Federal law still bans pot, but U.S. Attorney McGregor Scott said he will prioritize illegal weed rather than going after the world’s largest legal recreational marijuana market, a decision U.S. Attorney General Jeff Sessions has left to the discretion of top federal prosecutors.
“The reality of the situation is there is so much black market marijuana in California that we could use all of our resources going after just the black market and never get there,” Scott said.
Title: New Hampshire to boost number of medical marijuana dispensaries by 50%
Author: MJ Biz
Date: 30 May 2018
New Hampshire is on the verge of expanding its medical marijuana program from four to six dispensaries – a move that will add two businesses to an industry that’s been struggling financially but may be turning the corner.
Lawmakers this month passed legislation that calls for the two additional dispensaries in sparsely populated regions of the state.
Gov. Chris Sununu, a Republican, plans to sign the bill, press secretary Ben Vihstadt told Marijuana Business Daily on Tuesday.
New Hampshire’s MMJ program began in April 2016. And the state’s four existing MMJ businesses have been posting losses.